Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    Myasthenia Gravis
Show Display Options
Rank Status Study
21 Completed Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Condition: Refractory Generalized Myasthenia Gravis
Interventions: Biological: Eculizumab;   Drug: Placebo
22 Completed Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
Conditions: Myositis;   Myasthenia Gravis
Intervention: Drug: Rituximab
23 Completed Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
Condition: Myasthenia Gravid
Interventions: Biological: IVIG;   Procedure: PLEX
24 Completed
Has Results
The Evaluation of Belimumab in Myasthenia Gravis (MG)
Condition: Myasthaenia Gravis
Interventions: Biological: Belimumab;   Other: Placebo
25 Completed FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
Condition: Myasthenia Gravis
Interventions: Drug: tacrolimus;   Drug: placebo
26 Recruiting Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: HIZENTRA ®
27 Terminated Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Placebo;   Drug: 250 mg CK-2017357;   Drug: 500 mg CK-2017357
28 Recruiting A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: IGIV-C;   Drug: Placebo
29 Active, not recruiting ECU-MG-302: An Extension Trial of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis
Condition: Refractory Generalized Myasthenia Gravis
Intervention: Biological: Eculizumab
30 Recruiting Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: IGIV-C;   Drug: Placebo
31 Completed A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Condition: Myasthenia Gravis Generalised
Interventions: Drug: mycophenolate mofetil [CellCept];   Drug: Placebo
32 Completed A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: mycophenolate mofetil (CellCept);   Drug: placebo
33 Terminated Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: immune globulin
34 Unknown  The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
Condition: Myasthenia Gravis
Interventions: Drug: Azathioprine;   Drug: Leflunomide
35 Recruiting A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
Condition: Myasthenia Gravis
Intervention: Drug: Human normal immunoglobulin G (IgG)
36 Recruiting A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations
Condition: Myasthenic Crisis
Intervention: Biological: IGIV-C
37 Recruiting Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Myasthenia Gravis;   Myopathies;   Stroke;   Parkinson's Disease
Intervention:
38 Completed Therapeutic Plasma Exchange in MG
Condition: Myasthenia Gravis
Interventions: Other: Skin biopsy;   Other: Single Fiber Electromyography
39 Completed Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F
Condition: Myasthenia Gravis
Intervention:
40 Recruiting The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor
Conditions: Thymectomy;   Myasthenia Gravis
Interventions: Procedure: "3-Hole" subxiphorid and subcostal approach;   Procedure: Trans sternal approach;   Procedure: VATS approach

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Indicates status has not been verified in more than two years